• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels for gastric cancer-risk screening

Research Project

Project/Area Number 16K08889
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Medical sociology
Research InstitutionNiigata University of Health and Welfare

Principal Investigator

Saito Shota  新潟医療福祉大学, 医療経営管理学部, 助教 (60739465)

Co-Investigator(Kenkyū-buntansha) 赤澤 宏平  新潟大学, 医歯学総合病院, 教授 (10175771)
石川 卓  新潟大学, 医歯学総合病院, 准教授 (70586940)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Keywords費用対効果 / 胃がん / 検診 / ヘリコバクター・ピロリ菌 / マルコフモデル / 医療経済 / 個別化医療 / H.pylori / ペプシノゲン / 胃癌 / 医療経済学
Outline of Final Research Achievements

Helicobacter pylori infection and the degree of chronic atrophic gastritis are significant predictors for the development of gastric cancer, especially in the Japanese population. A combination of assays for serum anti-Helicobacter pylori immunoglobulin G antibody (HPA) and serum pepsinogen (PG) levels can be used to identify gastric cancer risk. In Japan, this ABC method may be an effective approach for identifying high-risk individuals who should undergo gastric cancer screening. The present study’s purpose was to estimate the long-term cost-effectiveness of the ABC method for assessing the gastric cancer risk in a Japanese population. We constructed a Markov cohort model to estimate the cost-effectiveness of ABC method. We suggested that a combination of HPA and serum PG assays plus scheduling endoscopy accordingly is a cost-effective strategy of screening for gastric cancer risk in Japan.

Academic Significance and Societal Importance of the Research Achievements

あらかじめ胃がんリスクを判定し、検診の必要性の少ない対象者と高い対象者を分類することは不要な検診費用を削減できるため極めて効率的な検診の運用方法である。日本の胃がんの発症率は諸外国と比較して非常に高く、発症予防と検診による早期発見に力を注ぐべき消化器疾患の1つとされている。ヘリコバクター・ピロリ菌の除菌治療による胃がんの発症予防とリスクの高い対象者へ集中的に精度の高いサーベイランスを行う検診方法の有用性が医療経済的な観点から示された。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (3 results)

All 2018 2017

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (2 results) (of which Int'l Joint Research: 1 results)

  • [Journal Article] Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.2018

    • Author(s)
      Saito S, Azumi M, Muneoka Y, Nishino K, Ishikawa T, Sato Y, Terai S, Akazawa K.
    • Journal Title

      The European Journal of Health Economics

      Volume: 19(4) Issue: 4 Pages: 545-555

    • DOI

      10.1007/s10198-017-0901-y

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Presentation] ヘリコバクター・ピロリ抗体検査と血清ペプシノゲン検査による 胃がんリスク層別化検診の医療経済効果の推定2017

    • Author(s)
      齋藤 翔太、石川 卓、赤澤 宏平
    • Organizer
      第37回日本医療情報学連合大会
    • Related Report
      2017 Research-status Report
  • [Presentation] ECONOMIC EVALUATION OF USING A COMBINATION OF HELICOBACTER PYLORI ANTIBODY AND SERUM PEPSINOGEN LEVELS FOR GASTRIC CANCER-RISK SCREENING IN JAPAN2017

    • Author(s)
      Saito S, Ishikawa T, Akazawa K
    • Organizer
      ISPOR 20th Annual European Congress
    • Related Report
      2017 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi